Lonza EasyDiff supplements for bone marrow CD34+

Friday, 22 July, 2011 | Supplied by: Lonza Australia Pty Ltd



Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.

Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.

There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.

The supplements are suitable for both drug discovery and toxicology research.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd